4-Nonylphenol mediated tumor progression and immune modulation through CDK2: Computational and experimental

Xianhuan Zhou1, Yuan Wei2, Yongzhi Tu3

  • 1Department of Gastroenterological Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China; Shantou University Medical College, Shantou, Guangdong 515041, China.

Insights

4-nonylphenol (4-NP), an endocrine disruptor in water, promotes cancer by activating oncogenic signaling pathways and suppressing immune responses. This study reveals its carcinogenic mechanisms and provides a framework for assessing environmental toxicant risks.

Area of Science:

  • Environmental Toxicology
  • Cancer Biology
  • Computational Chemistry

Background:

  • 4-nonylphenol (4-NP) is an endocrine-disrupting chemical found in water systems globally.
  • Elevated 4-NP levels are linked to cancer progression.
  • Understanding 4-NP's carcinogenic mechanisms is crucial for public health.

Purpose of the Study:

  • To systematically investigate the carcinogenic mechanisms of 4-NP.
  • To identify oncogenic targets and prognostic markers associated with 4-NP exposure.
  • To establish a computational-experimental framework for environmental toxicant assessment.

Main Methods:

  • Network toxicology
  • Machine learning
  • Molecular docking simulations
  • Single-cell RNA sequencing
  • Spatial transcriptomics
  • Pan-cancer expression profiling
  • Breast cancer cell line experiments

Main Results:

  • Identified six high-affinity 4-NP-binding targets: TNF, CDK2, PRKCA, ERBB2, CASP8, and MAPK3.
  • Elucidated mechanisms involving MAPK signaling pathway activation and CD8+ T-cell exhaustion.
  • Validated 4-NP's role in promoting cell proliferation and CDK2 expression in breast cancer cells.

Conclusions:

  • 4-NP acts as a potential carcinogen by disrupting cellular signaling and immune surveillance.
  • The study provides a novel computational-experimental framework for evaluating environmental toxicants.
  • Findings offer insights for preventive strategies against pollutant-driven cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...